- CA$10.95m
- CA$15.25m
- CA$6.26m
- 72
- 51
- 42
- 55
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4.44 | 5.23 | 6.05 | 5.98 | 6.26 |
Cost of Revenue | |||||
Gross Profit | 3.72 | 4.31 | 5.42 | 5.27 | 5.69 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 5.47 | 6.18 | 6.79 | 8.13 | 7.92 |
Operating Profit | -1.04 | -0.948 | -0.745 | -2.15 | -1.65 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -1.07 | -1.18 | -1.3 | -2.66 | -2.04 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1.07 | -1.18 | -1.3 | -2.66 | -2.04 |
Net Income Before Extraordinary Items | |||||
Net Income | -1.07 | -1.18 | -1.3 | -2.66 | -2.04 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1.07 | -1.18 | -1.3 | -2.66 | -2.04 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.014 | -0.015 | -0.016 | -0.024 | -0.008 |